Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 1996
[Treatment with growth factors and cytokines in hematologic diseases]A Waage, I M Dahl, S A Evensen, et al.Bone Marrow Transplantation|June 1, 2004
Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrowD Heldal, L Brinch, S A Evensen, et al.Scandinavian Journal of Infectious Diseases|January 1, 1991
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor poolsH Rollag, G Patou, J R Pattison, et al.Bone Marrow Transplantation|January 22, 2000
The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantationM J Hjermstad, J H Loge, S A Evensen, et al.Bone Marrow Transplantation|June 13, 2000
A randomised study of allogeneic transplantation with stem cells from blood or bone marrowD Heldal, G Tjønnfjord, L Brinch, et al.Bone Marrow Transplantation|July 15, 2003
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre studyD Heldal, L Brinch, G Tjønnfjord, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1991
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]L Brinch, S A Evensen, D Albrechtsen, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1996
[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]H Holte, S O Kvaløy, T Engan, et al.Bone Marrow Transplantation|April 18, 2002
Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaintsD Heldal, L Brinch, G Tjønnfjord, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemiaG Juliusson, D Heldal, E Hippe, et al.Pageof 12